It's worth being precise here rather than overselling the point: published research on individual versus group therapy for addiction and mental health treatment is genuinely mixed. A 2019 systematic review and meta-analysis in the Journal of Substance Abuse Treatment found a small but statistically significant effect favoring group therapy specifically on abstinence outcomes, with no significant differences found on substance-use frequency, attrition, or overall wellbeing. One-on-one care isn't the clinically superior format in general — that claim isn't well supported by the evidence.

What the Broader Literature Actually Shows
An earlier narrative review of group therapy outcome literature for substance use disorders similarly found no consistent advantage for one format over the other across the studies available at the time. A separate 25-year meta-analytic look at outcome differences between individual and group treatment formats found that much of the apparent disagreement in the field traces back to differences in how studies control for treatment content, patient population, and dose — not to a genuine, reproducible superiority of either format. A randomized trial comparing individual versus group cognitive behavioral therapy for alcohol use disorder found broadly comparable outcomes between formats, reinforcing that format alone is rarely the decisive variable in treatment effectiveness.
The Actual Reason High-Profile Clients Choose It
The actual reason high-profile clients often choose one-on-one care is more specific and more honest: group formats require disclosing your presence and often your condition to a room of other clients. For someone whose identity, role, or public profile makes that disclosure a real risk — reputational, professional, or personal — that structural requirement is disqualifying regardless of the format's average outcomes. The choice is about confidentiality fit for this specific population, not a universal claim about which format works better.
Confidentiality protections for substance use treatment records are also a live regulatory topic in the United States. Federal rules governing how substance use disorder treatment records can be shared — commonly known as 42 CFR Part 2 — exist precisely because disclosure risk in this area is treated as materially different from ordinary medical privacy. A qualitative analysis of how these federal confidentiality rules affect care coordination illustrates how seriously disclosure risk is treated in U.S. addiction treatment policy generally, independent of any single facility's internal privacy practices.
How That Shapes the Program
That one-to-one structure is a core part of the Pouyan Method™, and it's the reason our executive rehab program runs no group sessions at all. Guests move through medically supervised detox, individual therapy, and, where clinically appropriate, modalities such as ibogaine treatment or ayahuasca ceremonies — always delivered one-on-one, never in a shared cohort setting.

Weighing the Trade-Off Honestly
Choosing one-on-one care over group therapy is a trade-off, not a strict upgrade. Group formats offer peer accountability, shared experience, and — per some of the research above — a modest statistical edge on abstinence outcomes in certain populations. What one-on-one care buys instead is control over who knows about your treatment at all. For a public figure, an executive under contractual scrutiny, or anyone whose professional standing depends on discretion, that trade-off is usually worth making even without a guaranteed clinical advantage. For someone without those exposure concerns, a well-run group program remains a legitimate, evidence-supported choice, and we say so plainly rather than overstating the case for our own model.
For readers weighing this decision for themselves or a family member, our luxury rehab program page and full treatment index describe how individualized care plans are built, and our admissions team can walk through which structure fits a specific situation.
References
- Group treatment for substance use disorder in adults: A systematic review and meta-analysis of randomized-controlled trials. Journal of Substance Abuse Treatment, 2019.
- Group therapy for substance use disorders: what do we know? PubMed, 2005.
- Outcome differences between individual and group formats: A 25-year meta-analytic perspective. PubMed, 2016.
- Individual versus Group Female-Specific Cognitive Behavior Therapy for Alcohol Use Disorder. PMC, 2018.
- The Perceived Impact of 42 CFR Part 2 on Coordination and Integration of Care: A Qualitative Analysis. PubMed, 2016.
- Group versus individual treatment for substance use disorders: the COMDAT trial protocol. PMC.

